ID   TGFR1_RAT               Reviewed;         501 AA.
AC   P80204;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   02-OCT-2024, entry version 198.
DE   RecName: Full=TGF-beta receptor type-1;
DE            Short=TGFR-1;
DE            EC=2.7.11.30;
DE   AltName: Full=Serine/threonine-protein kinase receptor R4;
DE            Short=SKR4;
DE   AltName: Full=TGF-beta type I receptor;
DE   AltName: Full=Transforming growth factor-beta receptor type I;
DE            Short=TGF-beta receptor type I;
DE            Short=TbetaR-I;
DE   Flags: Precursor;
GN   Name=Tgfbr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Urogenital ridge;
RX   PubMed=8395914; DOI=10.1002/aja.1001960207;
RA   He W.-W., Gustafson M.L., Hirobe S., Donahoe P.K.;
RT   "Developmental expression of four novel serine/threonine kinase receptors
RT   homologous to the activin/transforming growth factor-beta type II receptor
RT   family.";
RL   Dev. Dyn. 196:133-142(1993).
RN   [2]
RP   INTERACTION WITH FKBP1A, AND ACTIVITY REGULATION.
RX   PubMed=8756725; DOI=10.1016/s0092-8674(00)80116-6;
RA   Wang T., Li B.Y., Danielson P.D., Shah P.C., Rockwell S., Lechleider R.J.,
RA   Martin J., Manganaro T., Donahoe P.K.;
RT   "The immunophilin FKBP12 functions as a common inhibitor of the TGF beta
RT   family type I receptors.";
RL   Cell 86:435-444(1996).
RN   [3]
RP   SUMOYLATION AT LYS-389.
RX   PubMed=18469808; DOI=10.1038/ncb1728;
RA   Kang J.S., Saunier E.F., Akhurst R.J., Derynck R.;
RT   "The type I TGF-beta receptor is covalently modified and regulated by
RT   sumoylation.";
RL   Nat. Cell Biol. 10:654-664(2008).
CC   -!- FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-
CC       beta type II serine/threonine kinase receptor, TGFBR2, the non-
CC       promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3.
CC       Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to
CC       the cytoplasm and is thus regulating a plethora of physiological and
CC       pathological processes including cell cycle arrest in epithelial and
CC       hematopoietic cells, control of mesenchymal cell proliferation and
CC       differentiation, wound healing, extracellular matrix production,
CC       immunosuppression and carcinogenesis. The formation of the receptor
CC       complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound
CC       to the cytokine dimer results in the phosphorylation and the activation
CC       of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1
CC       phosphorylates SMAD2 which dissociates from the receptor and interacts
CC       with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the
CC       nucleus where it modulates the transcription of the TGF-beta-regulated
CC       genes. This constitutes the canonical SMAD-dependent TGF-beta signaling
CC       cascade. Also involved in non-canonical, SMAD-independent TGF-beta
CC       signaling pathways. For instance, TGFBR1 induces TRAF6
CC       autoubiquitination which in turn results in MAP3K7 ubiquitination and
CC       activation to trigger apoptosis. Also regulates epithelial to
CC       mesenchymal transition through a SMAD-independent signaling pathway
CC       through PARD6A phosphorylation and activation (By similarity).
CC       {ECO:0000250|UniProtKB:P36897}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[receptor-protein] = ADP + H(+) + O-phospho-
CC         L-threonyl-[receptor-protein]; Xref=Rhea:RHEA:44880, Rhea:RHEA-
CC         COMP:11024, Rhea:RHEA-COMP:11025, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977,
CC         ChEBI:CHEBI:456216; EC=2.7.11.30;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[receptor-protein] = ADP + H(+) + O-phospho-L-
CC         seryl-[receptor-protein]; Xref=Rhea:RHEA:18673, Rhea:RHEA-COMP:11022,
CC         Rhea:RHEA-COMP:11023, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;
CC         EC=2.7.11.30;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Kept in an inactive conformation by FKBP1A
CC       preventing receptor activation in absence of ligand. CD109 is another
CC       inhibitor of the receptor. {ECO:0000269|PubMed:8756725}.
CC   -!- SUBUNIT: Homodimer; in the endoplasmic reticulum but also at the cell
CC       membrane. Heterohexamer; TGFB1, TGFB2 and TGFB3 homodimeric ligands
CC       assemble a functional receptor composed of two TGFBR1 and TGFBR2
CC       heterodimers to form a ligand-receptor heterohexamer. The respective
CC       affinity of TGBRB1 and TGFBR2 for the ligands may modulate the kinetics
CC       of assembly of the receptor and may explain the different biological
CC       activities of TGFB1, TGFB2 and TGFB3. Component of a complex composed
CC       of TSC22D1 (via N-terminus), TGFBR1 and TGFBR2; the interaction between
CC       TSC22D1 and TGFBR1 is inhibited by SMAD7 and promoted by TGFB1 (By
CC       similarity). Interacts with CD109; inhibits TGF-beta receptor
CC       activation in keratinocytes. Interacts with RBPMS. Interacts with
CC       SMAD2, SMAD3 and ZFYVE9; ZFYVE9 recruits SMAD2 and SMAD3 to the TGF-
CC       beta receptor. Interacts with TRAF6 and MAP3K7; induces MAP3K7
CC       activation by TRAF6. Interacts with PARD6A; involved in TGF-beta
CC       induced epithelial to mesenchymal transition. Interacts with NEDD4L (By
CC       similarity). Interacts with SMAD7, SMURF1 and SMURF2; SMAD7 recruits
CC       NEDD4L, SMURF1 and SMURF2 to the TGF-beta receptor (By similarity).
CC       Interacts with USP15 and VPS39 (By similarity). Interacts
CC       (unphosphorylated) with FKBP1A; prevents TGFBR1 phosphorylation by
CC       TGFBR2 and stabilizes it in the inactive conformation. Interacts with
CC       SDCBP (via C-terminus) (By similarity). Interacts with CAV1 and this
CC       interaction is impaired in the presence of SDCBP (By similarity).
CC       Interacts with APPL1; interaction is TGF beta dependent; mediates
CC       trafficking of the TGFBR1 from the endosomes to the nucleus via
CC       microtubules in a TRAF6-dependent manner (By similarity). Interacts
CC       with GPR50; this interaction promotes the constitutive activation of
CC       SMAD signaling pathway (By similarity). {ECO:0000250|UniProtKB:P36897,
CC       ECO:0000269|PubMed:8756725}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P36897};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P36897}.
CC       Cell junction, tight junction {ECO:0000250|UniProtKB:P36897}. Membrane
CC       raft {ECO:0000250|UniProtKB:P36897}. Cell surface
CC       {ECO:0000250|UniProtKB:P36897}.
CC   -!- TISSUE SPECIFICITY: Urogenital ridge, testis, ovary, brain and lungs.
CC   -!- PTM: Phosphorylated at basal levels in the absence of ligand. Activated
CC       upon phosphorylation by TGFBR2, mainly in the GS domain.
CC       Phosphorylation in the GS domain abrogates FKBP1A-binding (By
CC       similarity). {ECO:0000250|UniProtKB:P36897}.
CC   -!- PTM: N-Glycosylated. {ECO:0000250|UniProtKB:P36897}.
CC   -!- PTM: Ubiquitinated; undergoes ubiquitination catalyzed by several E3
CC       ubiquitin ligases including SMURF1, SMURF2 and NEDD4L2. Results in the
CC       proteasomal and/or lysosomal degradation of the receptor thereby
CC       negatively regulating its activity. Deubiquitinated by USP15, leading
CC       to stabilization of the protein and enhanced TGF-beta signal. Its
CC       ubiquitination and proteasome-mediated degradation is negatively
CC       regulated by SDCBP (By similarity). {ECO:0000250|UniProtKB:P36897}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L26110; AAA83216.1; -; mRNA.
DR   RefSeq; XP_006238092.2; XM_006238030.3.
DR   AlphaFoldDB; P80204; -.
DR   SMR; P80204; -.
DR   BioGRID; 248223; 2.
DR   CORUM; P80204; -.
DR   IntAct; P80204; 4.
DR   MINT; P80204; -.
DR   STRING; 10116.ENSRNOP00000009452; -.
DR   ChEMBL; CHEMBL4523265; -.
DR   GlyCosmos; P80204; 1 site, No reported glycans.
DR   GlyGen; P80204; 1 site.
DR   PhosphoSitePlus; P80204; -.
DR   PaxDb; 10116-ENSRNOP00000009452; -.
DR   GeneID; 29591; -.
DR   UCSC; RGD:3852; rat.
DR   AGR; RGD:3852; -.
DR   CTD; 7046; -.
DR   RGD; 3852; Tgfbr1.
DR   eggNOG; KOG2052; Eukaryota.
DR   HOGENOM; CLU_000288_8_1_1; -.
DR   InParanoid; P80204; -.
DR   OrthoDB; 3900892at2759; -.
DR   PhylomeDB; P80204; -.
DR   TreeFam; TF314724; -.
DR   BRENDA; 2.7.10.2; 5301.
DR   BRENDA; 2.7.11.30; 5301.
DR   Reactome; R-RNO-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-RNO-2173789; TGF-beta receptor signaling activates SMADs.
DR   Reactome; R-RNO-2173791; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition).
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-9839389; TGFBR3 regulates TGF-beta signaling.
DR   PRO; PR:P80204; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0048179; C:activin receptor complex; IBA:GO_Central.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0005923; C:bicellular tight junction; ISO:RGD.
DR   GO; GO:0005901; C:caveola; IDA:MGI.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0070021; C:transforming growth factor beta ligand-receptor complex; ISO:RGD.
DR   GO; GO:0048185; F:activin binding; IBA:GO_Central.
DR   GO; GO:0016361; F:activin receptor activity, type I; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IMP:RGD.
DR   GO; GO:0070411; F:I-SMAD binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IMP:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IMP:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0046332; F:SMAD binding; ISO:RGD.
DR   GO; GO:0050431; F:transforming growth factor beta binding; IDA:RGD.
DR   GO; GO:0005024; F:transforming growth factor beta receptor activity; ISO:RGD.
DR   GO; GO:0005025; F:transforming growth factor beta receptor activity, type I; IMP:RGD.
DR   GO; GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0005114; F:type II transforming growth factor beta receptor binding; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:RGD.
DR   GO; GO:0032924; P:activin receptor signaling pathway; ISS:AgBase.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0060978; P:angiogenesis involved in coronary vascular morphogenesis; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0048844; P:artery morphogenesis; ISO:RGD.
DR   GO; GO:0001824; P:blastocyst development; ISO:RGD.
DR   GO; GO:0060317; P:cardiac epithelial to mesenchymal transition; ISS:AgBase.
DR   GO; GO:0048870; P:cell motility; ISO:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IBA:GO_Central.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:RGD.
DR   GO; GO:0030199; P:collagen fibril organization; ISO:RGD.
DR   GO; GO:0060982; P:coronary artery morphogenesis; ISO:RGD.
DR   GO; GO:0048565; P:digestive tract development; IEP:RGD.
DR   GO; GO:0007566; P:embryo implantation; IEP:RGD.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; ISO:RGD.
DR   GO; GO:0042118; P:endothelial cell activation; ISS:AgBase.
DR   GO; GO:0043542; P:endothelial cell migration; ISO:RGD.
DR   GO; GO:0001935; P:endothelial cell proliferation; ISO:RGD.
DR   GO; GO:1905223; P:epicardium morphogenesis; ISO:RGD.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0046847; P:filopodium assembly; ISO:RGD.
DR   GO; GO:0008354; P:germ cell migration; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISS:AgBase.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:AgBase.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0002088; P:lens development in camera-type eye; ISO:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0008584; P:male gonad development; ISO:RGD.
DR   GO; GO:0048762; P:mesenchymal cell differentiation; ISS:AgBase.
DR   GO; GO:0036446; P:myofibroblast differentiation; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; IMP:RGD.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:1902894; P:negative regulation of miRNA transcription; IMP:BHF-UCL.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0048663; P:neuron fate commitment; ISO:RGD.
DR   GO; GO:0060017; P:parathyroid gland development; ISO:RGD.
DR   GO; GO:0060037; P:pharyngeal system development; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:AgBase.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISS:AgBase.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:1905007; P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; ISO:RGD.
DR   GO; GO:1901203; P:positive regulation of extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:AgBase.
DR   GO; GO:1902462; P:positive regulation of mesenchymal stem cell proliferation; ISO:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; IMP:BHF-UCL.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0060391; P:positive regulation of SMAD protein signal transduction; ISO:RGD.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; ISO:RGD.
DR   GO; GO:1905075; P:positive regulation of tight junction disassembly; ISO:RGD.
DR   GO; GO:1904018; P:positive regulation of vasculature development; ISO:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0060043; P:regulation of cardiac muscle cell proliferation; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010717; P:regulation of epithelial to mesenchymal transition; ISS:AgBase.
DR   GO; GO:0010468; P:regulation of gene expression; ISS:AgBase.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0070723; P:response to cholesterol; ISO:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IDA:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0034695; P:response to prostaglandin E; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0060021; P:roof of mouth development; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0048705; P:skeletal system morphogenesis; ISO:RGD.
DR   GO; GO:0048538; P:thymus development; ISO:RGD.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:RGD.
DR   GO; GO:0003223; P:ventricular compact myocardium morphogenesis; ISO:RGD.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISO:RGD.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; ISO:RGD.
DR   CDD; cd14143; STKc_TGFbR1_ACVR1b_ACVR1c; 1.
DR   Gene3D; 2.10.60.10; CD59; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR000472; Activin_recp.
DR   InterPro; IPR003605; GS_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR045860; Snake_toxin-like_sf.
DR   InterPro; IPR000333; TGFB_receptor.
DR   PANTHER; PTHR23255:SF61; TGF-BETA RECEPTOR TYPE-1; 1.
DR   PANTHER; PTHR23255; TRANSFORMING GROWTH FACTOR-BETA RECEPTOR TYPE I AND II; 1.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF08515; TGF_beta_GS; 1.
DR   SMART; SM00467; GS; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF57302; Snake toxin-like; 1.
DR   PROSITE; PS51256; GS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Cell junction; Cell membrane; Differentiation;
KW   Disulfide bond; Glycoprotein; Growth regulation; Isopeptide bond; Kinase;
KW   Magnesium; Manganese; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Receptor; Reference proteome;
KW   Serine/threonine-protein kinase; Signal; Tight junction; Transferase;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000250"
FT   CHAIN           30..501
FT                   /note="TGF-beta receptor type-1"
FT                   /id="PRO_0000024425"
FT   TOPO_DOM        30..124
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        125..145
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        146..501
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          173..202
FT                   /note="GS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00585"
FT   DOMAIN          203..493
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOTIF           191..192
FT                   /note="FKBP1A-binding"
FT   ACT_SITE        331
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         209..217
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         230
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   MOD_RES         183
FT                   /note="Phosphothreonine; by TGFBR2"
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   MOD_RES         184
FT                   /note="Phosphothreonine; by TGFBR2"
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   MOD_RES         185
FT                   /note="Phosphoserine; by TGFBR2"
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   MOD_RES         187
FT                   /note="Phosphoserine; by TGFBR2"
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   MOD_RES         189
FT                   /note="Phosphoserine; by TGFBR2"
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        32..50
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   DISULFID        34..37
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   DISULFID        44..67
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   DISULFID        82..94
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   DISULFID        95..100
FT                   /evidence="ECO:0000250|UniProtKB:P36897"
FT   CROSSLNK        389
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
SQ   SEQUENCE   501 AA;  56000 MW;  EAD7F8D37E456102 CRC64;
     MEAASAALRR CLLLIVLVAA ATLLPGAKAL QCFCHLCTKD NFTCETDGLC FVSVTETTDK
     VIHNSMCIAE IDLIPRDRPF VCAPSSKTGA VTYCCNQDHC NKIELPTTGP FSEKQSAGLG
     PVELAAVIAG PVCFVCIALM LMVYICHNRT VIHHRVPNEE DPSLDRPFIS EGTTLKDLIY
     DMTTSGSGSG LPLLVQRTIA RTIVLQESIG KGRFGEVWRG KWRGEEVAVK IFSSREERSW
     FREAEIYQTV MLRHENILGF IAADNKDNGT WTQLWLVSDY HEHGSLFDYL NRYTVTVEGM
     IKLALSTASG LAHLHMEIVG TQGKPAIAHR DLKSKNILVK KNGTCCIADL GLAVRHDSAT
     DTIDIAPNHR VGTKRYMAPE VLDDSINMKH FESFKRADIY AMGLVFWEIA RRCSIGGIHE
     DYQLPYYDLV PSDPSVEEMR KVVCEQKLRP NIPNRWQSCE ALRVMAKIMR ECWYANGAAR
     LTALRIKKTL SQLSQQEGIK M
//
